External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

AAN 2021

-
Coming soon
03:00 PM
Duration 4mins Virtual
Preliminary Results of Ongoing, Prospective Study of Antibody and T-Cell Responses to SARS-CoV-2 in Patients With MS on Ocrelizumab▼ or Other Disease-Modifying Therapies
Kister I, Krogsgaard M, Mulligan MJ, Patskovsky Y, Voloshyna I, Ferstler N, Zhotvis Ryerson L, Curtin R, Kim J, Tardio E, Rimler Z, Sherman K, Samanovic-Golden M, Cornelius A, Pedotti R, Raposo C, Priest J, Hawker K, Silverman GJ

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
04:00 PM
Duration 8mins Virtual
The Safety of Fenebrutinib in a Large Population of Patients With Diverse Autoimmune Conditions Supports Investigation in Multiple Sclerosis
Oh J, Cohen S, Isenberg D, Maurer M, Galanter JM*, Chu T*, Teterina A, Mackey H, Goodyear A, Mandel C, Lee C, Tuckwell K, Lim J, Vanevski KM, Giovannoni G

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar